Sort
15,273 grants matching “antimicrobial resistance”
Antimicrobial Blue Light for the Treatment of Otitis Media
$489,500Tianhong Dai · Massachusetts General Hospital · R21 · FY2025 · DC
Human cellular models of TB and innate immunity
$489,500Anne Goldfeld · Boston Children'S Hospital · R21 · FY2025 · AI
Staphylococcus aueaus vaccine development
$489,334Juliane Bubeck Wardenburg · University Of Chicago · U54 · FY2012 · AI
The LiaFSR system and antimicrobial peptide resistance in enterococci
$489,288Cesar Augusto Arias · Methodist Hospital Research Institute · R01 · FY2022 · AI
Dissecting the role of sialic acid and sialidase in the pathophysiology of Porphyromonas gingivalis
$489,207Chunhao Li · Virginia Commonwealth University · R01 · FY2023 · DE
Dissecting the role of sialic acid and sialidase in the pathophysiology of Porphyromonas gingivalis
$489,207Chunhao Li · Virginia Commonwealth University · R01 · FY2021 · DE
Dissecting the role of sialic acid and sialidase in the pathophysiology of Porphyromonas gingivalis
$489,207Chunhao Li · Virginia Commonwealth University · R01 · FY2025 · DE
Optimizing Antimicrobial Use in Maintenance Dialysis Units (OPTIMUS)
$489,153Erika M D'agata · Rhode Island Hospital · R01 · FY2020 · HS
Role of the environmental sensor, AhR on colitis
$489,036Prakash S. Nagarkatti · University Of South Carolina At Columbia · R01 · FY2025 · AI
Cell-mediated protection against pneumonic plague
$489,018Stephen T Smiley · Trudeau Institute, Inc. · R01 · FY2010 · AI
Enhancing Patient Safety by Preventing Urinary Tract Infection in Post-Acute Care
$488,948Lona Mody · University Of Michigan At Ann Arbor · R01 · FY2017 · HS
Elucidating the molecular basis of piperaquine resistance in Plasmodium falciparum
$488,795David Armand Fidock · Columbia University Health Sciences · R01 · FY2025 · AI
Decoding cell surface chemistry and function in Staphylococcus aureus
$488,783Lynette S Cegelski · Stanford University · R35 · FY2025 · GM
Host Defense Training in Allergy and Infectious Diseases
$488,762Wesley C Van Voorhis · University Of Washington · T32 · FY2011 · AI
Predictive Modeling of Influenza-Pneumococcal Coinfection
$488,716Amber M Smith · University Of Tennessee Health Sci Ctr · R01 · FY2021 · AI
Reducing Use of Antibiotics without a Prescription among Outpatients in a Safety Net Healthcare System
$488,678Barbara Wells Trautner · Baylor College Of Medicine · R01 · FY2022 · HS
Extensively drug resistant Pseudomonas aeruginosa keratitis outbreak strain:  virulence mechanisms and mitigation
$488,639Robert M Shanks · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · EY
Occupational Exposure and Health Risk from Dairy Microbiome and Resistome to Dairy Farm Workers
$488,461Gautam Dantas · Washington University · R01 · FY2020 · OH
Occupational Exposure and Health Risk from Dairy Microbiome and Resistome to Dairy Farm Workers
$488,461Gautam Dantas · Washington University · R01 · FY2021 · OH
Randomized Intervention for Children with Vesicoureteral Reflux
$488,448Ron Keren · Children'S Hosp Of Philadelphia · U01 · FY2009 · DK
Clinical Trial of Prophylactic Antibiotics for Children with Vesicoureteral Reflu
$488,448Ron Keren · Children'S Hosp Of Philadelphia · U01 · FY2008 · DK
Efficacy of oral vancomycin prophylaxis for prevention of recurrent C. difficile infection
$488,150Nasia Safdar · University Of Wisconsin-Madison · R01 · FY2018 · HS
Revisiting alginate paradigms
$488,142Daniel J Wozniak · Ohio State University · R01 · FY2022 · AI
Revisiting alginate paradigms
$488,142Daniel J Wozniak · Ohio State University · R01 · FY2021 · AI
Type VI secretion effectors and interbacterial competition in vivo
$488,116Joseph David Mougous · University Of Washington · R01 · FY2015 · AI